Examination Report |
1 | TM-A(TRADE MARKS APPLICATION) | 11 Aug 2020 |
2 | Reply to Exam Report (MIS-R) | 03 Nov 2020 |
3 | Authorization Letter | 01 Aug 2022 |
4 | Documents in support of Show cause Hearing (SCH) | 03 Aug 2022 |
5 | Journal Copy | 08 Oct 2022 |
6 | Certificate | 04 Jan 2023 |
7 | TM-M(REQUEST SUBMITTING AUTHORISATION OF AGENT) | 24 Jul 2024 |
1 | EXAMINATION REPORT | 10356338 | 02 Sep 2020 | |
2 | Hearing Notice (Show Cause) | 12438410 | 09 Nov 2021 | |
3 | Hearing Notice (Show Cause) | 13338255 | 12 Apr 2022 | |
4 | Hearing Notice (Show Cause) | 13738985 | 05 Jul 2022 | |
5 | Tribunal Accepted Notice for : 4605051 | 13931561 | 5686596 | 11 Aug 2022 |
The application for Endofert was made on 11 August 2020.
The trademark applicant for Endofert is INTAS PHARMACEUTICALS.
Endofert is applied in class(es) 5.
Application for Endofert is on Registered stage.
Application Id allotted to Endofert is 4605051.
Trademark agent or attorney for the application is Y. J. Trivedi & Co.
Endofert filed with the Intellectual property office as a WORD.